Heights Capital Management, Inc. recently announced the acquisition of new stake in Gevo Inc. (NASDAQ:GEVO). This fresh investment now brings its stake to 21.12% valued currently at $4.22 million. In addition, Altium Capital Management LP raised its holdings by 2.67 million to 2.67 million shares.

With over 43.73 million Gevo Inc. (GEVO) shares trading Monday and a closing price of $1.25 on the day, the dollar volume was approximately $54.66 million. The shares have shown a negative weekly performance of -10.07% and its price on 08/31/20 gained nearly 4.17%. Currently, there are 75.73M common shares owned by the public and among those 49.54M shares have been available to trade.

Incidentally, analysts’ outlook for the Gevo Inc. stock is 2.00 for the next 12 months.

Insiders at the company have transacted a total of 38 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, accounting for 3,740,037 shares. Insider sales of the common stock occurred on 17 occasions, with total insider shares sold totaling 253,432 shares.

The top 3 mutual fund holders in Gevo Inc. are Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and Fidelity Extended Market Index Fu. Vanguard Total Stock Market Index owns 0.19 million shares of the company’s stock, all valued at over $0.11 million. Fidelity Extended Market Index Fu now owns shares totaling to 0.16% of the shares outstanding.

Shares of Gevo Inc. (NASDAQ: GEVO) opened at $1.28, up $0.08 from a prior closing price of $1.20. However, the script later closed the day at $1.25, up 4.17%. The company’s stock has a 5-day price change of -10.07% and -5.30% over the past three months. GEVO shares are trading -45.89% year to date (YTD), with the 12-month market performance down to -53.18% lower. It has a 12-month low price of $0.46 and touched a high of $3.60 over the same period. Currently, 43.73 million shares have been traded, compared to an average intraday trading volume of 31.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 48.14%, 63.16%, and -11.86% respectively.

Institutional ownership of Gevo Inc. (NASDAQ: GEVO) shares accounts for 1.50% of the company’s 75.73M shares outstanding. Mutual fund holders own 13.07%, while other institutional holders and individual stakeholders account for 38.78% and 1.16% respectively.

It has a market capitalization of $85.94M and a beta (3y monthly) value of 2.61. The earnings-per-share (ttm) stands at -$2.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 18.45% over the week and 19.22% over the month.

Analysts forecast that Gevo Inc. (GEVO) will achieve an EPS of -$0.11 for the current quarter, -$0.11 for the next quarter and -$0.16 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.12 while analysts give the company a high EPS estimate of -$0.1. Comparatively, EPS for the current quarter was -$0.66 a year ago. Earnings per share for the fiscal year are expected to increase by 59.00%, and 75.20% over the next financial year.

If you are looking to buy this stock, then you may note that the average analyst recommendation by 2 brokerage firm advisors rate Gevo Inc. (GEVO) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 2 Wall Street analysts polled rate the stock as a buy, while 0 of the 2 advise that investors “hold,” and 0 rated it as a “Sell.”

Looking at the support for the GEVO, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on September 07, 2018, with the firm’s price target at. H.C. Wainwright coverage for the Gevo Inc. (GEVO) stock in a research note released on January 09, 2018 offered a Neutral rating with a price target of $12. Rodman & Renshaw was of a view on January 13, 2017 that the stock is Buy, while UBS gave the stock Sell rating on September 26, 2012, issuing a price target of $9- $1. Canaccord Genuity on their part issued Buy rating on September 25, 2012.